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Abstract
Background: Takotsubo cardiomyopathy (TSCM) has detrimental effects on both physical and psychological health of 
sufferers. However, little is known whether TSCM also affects sexual functioning in female patients.
Aim: The aim of this study was to investigate psychological distress (depression and anxiety), health-related quality of life, 
and sexual functioning in women with TSCM and compare them with women with acute myocardial infarction and with 
healthy controls.
Methods: A three group prospective case–control design was used. Female patients with TSCM or acute myocardial 
infarction, as well as healthy controls (94 in each group), were recruited across eight Iranian university hospitals. Data 
were collected at baseline and after six and 18 months using the Hospital Anxiety and Depression Scale, the Short Form-
12, the Female Sexual Function Index and the Female Sexual Distress Scale. Multilevel logistic regression was conducted.
Results: The TSCM group showed worst sexual functioning and the highest level of anxiety and depression at baseline (p<0.01) 
compared with the two other groups. The TSCM and AMI groups showed comparable health-related quality of life at baseline, 
which was lower in both groups compared with the healthy controls (p<0.01). Overall, depression, anxiety and health-related 
quality of life showed a significant change over time, especially in the TSCM group, with health-related quality of life decreasing, 
while anxiety and depression were increasing. Compared with the acute myocardial infarction and healthy control groups, the 
TSCM group showed a higher prevalence of sexual problems (odds ratios = 3.10 and 2.28, respectively) across time. Moreover, 
sexual functioning was found to be a mediator between anxiety and health-related quality of life in the TSCM group.
Conclusion: Depression, anxiety, health-related quality of life, and sexual dysfunction tend to increase over time in 
female patients with TSCM; thus, healthcare providers should pay attention to these problems and provide appropriate 
treatment where necessary.
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Introduction
Takotsubo cardiomyopathy (TSCM), also known as ‘stress 
cardiomyopathy’, shows similar symptoms to acute myo-
cardial infarction (AMI), such as shortness of breath and/
or chest pain.1 In contrast to AMI, however, TSCM symp-
toms are based on a temporary occlusion of the coronary 
arteries that may be induced primarily by catecholamine 
release and which usually disappears after a couple of days 
or weeks.1 Different prevalence rates for TSCM have been 
observed ranging from 0.7% to 3.0%. Furthermore, mor-
tality rates of up to 8% have been reported if patients do 
not receive appropriate and timely treatment.2,3 In addition 
to physical distress, a variety of psycho-affective triggers 
and predispositions such as stress, anxiety, depression, 
phobia and anhedonia have been recognized as potential 
risk factors for TSCM.4,5 Moreover, gender and age might 
be considered predisposing factors too, given that more 
than 90% of all reported cases occur in women aged 
between 58 and 75 years.1 The differential diagnosis is not 
always straightforward and a recent study from the United 
States showed that up to 5% of women were misdiagnosed 
with AMI while actually suffering from TSCM.6
Sexual activity has long been recognized as an impor-
tant component of people’s health-related quality of life 
(HRQoL), which is also true for individuals suffering from 
cardiovascular disease (CVD).7,8 Decreased sexual activ-
ity and functioning are common in patients with CVD9 and 
are often interrelated with anxiety and depression,10–14 but 
seem to express themselves differently in men and 
women.15–17 According to previous studies involving 
patients with CVD, women suffer more frequently from 
impaired sexual functioning and its direct effects com-
pared with men.13 Furthermore, sexual satisfaction is asso-
ciated with female patients’ physical and psychological 
health, while in men sexual satisfaction seems to be asso-
ciated with physical health only.18,19 Given that psycho-
logical health is linked to a woman’s sexual satisfaction 
and that HRQoL is related to psychological distress in 
CVD patients,18–20 it is further likely that sexual function-
ing and sexual satisfaction might represent mediators in 
the association between psychological distress and 
HRQoL. More specifically, increased anxiety in women 
suffering from CVD may negatively impact on their sexual 
functioning and sexual satisfaction, subsequently leading 
to overall lower HRQoL. Emotional stressors have been 
shown to play an important role in TSCM disease develop-
ment and maintenance/worsening, and may further indi-
rectly and directly affect HRQoL in these patients. 
Therefore, investigation of these factors is crucial so that 
novel strategies for better disease management can be 
developed for female patients suffering from TSCM.
So far, no study has explored this link and while the 
occurrence of sexual problems in female patients suffer-
ing from CVD has been relatively well studied, to the best 
of our knowledge, no study has assessed sexual function-
ing in female patients suffering from TSCM. Given the 
differences in anxiety and depression between individuals 
with TSCM and those with acute coronary syndrome, 
including AMI, the effects of anxiety and depression on 
overall sexual health are likely to be different between 
TSCM and AMI patients.21
Aims
The objectives of the present longitudinal study were: 1) to 
investigate levels of psychological distress (symptoms of 
depression and anxiety), HRQoL and sexual functioning in 
women with TSCM at baseline and over an 18-month 
period, 2) to compare these levels with the levels of women 
with AMI and of a healthy control group, and 3) to deter-
mine potential associations between the psychological, 
sexual and HRQoL variables, as well as any significant 
mediation effect of sexual functioning and satisfaction.
Materials and methods
Design and study participants
This study was conducted as a multicenter longitudinal 
case–control study involving eight referral university hos-
pitals (five in Tehran, one in Qazvin, one in Tabriz and one 
in Zahedan). Both the TSCM and AMI patients were newly 
diagnosed and had not received any prior treatment before 
being included in the study. All participants were recruited 
between January 2012 and February 2015. The study was 
approved by the ethics committee of Qazvin University of 
Medical Sciences. All participants provided informed con-
sent prior to participation.
TSCM group. One hundred and sixty-three female patients 
with TSCM admitted to the emergency care units of the 
various hospitals were examined and screened for study 
eligibility by two trained general physicians. Patients were 
included in the TSCM group if they: 1) were diagnosed 
with TSCM according to the Mayo Clinic criteria,22 2) 
were married or had a partner, 3) were able to read and 
speak Persian, and 4) did not report a previous history of 
AMI (according to their medical records). Patients were 
excluded if they: 1) did not provide a written informed 
consent, 2) were diagnosed with severe stage of concurrent 
diseases such as cancer, renal failure and/or cognitive 
impairment, or 3) were undergoing hormone replacement 
therapy. Of the 163 approached female patients with 
TSCM, 58 were not eligible for inclusion in this study and 
11 did not provide written informed consent. In the end, 
n = 94 patients with TSCM were included in the study.
AMI group. Female patients who had been admitted to the 
same hospitals with clinical symptoms of AMI were 
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screened for their eligibility by two trained general physi-
cians. Subjects were included if they: 1) had a confirmed 
diagnosis of AMI by their attending physician, 2) were 
married or had a steady partner, 3) were able to read and 
speak Persian, and 4) did not report a previous history of 
TSCM according to their medical records. Patients were 
excluded if they: 1) did not provide written informed con-
sent, 2) were diagnosed with severe stage of concurrent 
diseases such as cancer, renal failure and/or cognitive 
impairment, and 3) were undergoing hormone replace-
ment therapy. In the end, n =94 patients with AMI were 
included in the study.
Healthy control group. A healthy control group of women 
was recruited among the TSCM and AMI patients’ rela-
tives and friends. Individuals were included as healthy 
controls if they: 1) were married or had a steady partner, 
and 2) did not have a history of TSCM, AMI and/or other 
CVDs (based on medical reports). Individuals were 
excluded if they: 1) were diagnosed with severe stage of 
concurrent diseases such as cancer, renal failure, and/or 
cognitive impairment, and 2) did not provide written 
informed consent. In the end, N =94 eligible age-matched 
healthy controls were included in the study.
Procedure
Patients were approached before their discharge from hos-
pital and screened by two trained general physicians in 
terms of their eligibility to be included in the study. A 
trained research nurse assistant provided detailed study 
information to the potential participants. Interested patients 
were then asked to provide written informed consent and 
to subsequently fill in all study measures at baseline. After 
six and 18 months, the patients and healthy controls were 
contacted again via phone by two trained research assis-
tants and asked to visit the university hospitals to recom-
plete the same measures for follow-up purposes.
Measures
Sociodemographic characteristics. Information on age, years 
of education, marriage duration, height and weight, family 
income, and smoking status was obtained via a semi-struc-
ture interview performed by two nurse research assistants. 
Clinical data on diabetes, hypertension, hyperlipidemia 
and menopausal status were obtained by reviewing the 
hospitals’ medical records.
Sexual functioning. Female sexual functioning was assessed 
using the Female Sexual Function Index (FSFI), a 19-item 
instrument consisting of six subscales: sexual desire (two 
items), arousal (four items), lubrication (four items), 
orgasm (three items), satisfaction (three items) and pain 
(three items). All items are scored on a five-point 
Likert-type scale ranging from 0 to 5 with an additional 
option of ‘no sexual activity’ for items 3 to 19. A total 
score can be obtained by summing up the six subscales. 
Higher FSFI scores indicate higher level of sexual func-
tioning. A previous validation study has suggested a 
total FSFI score of ⩽ 26.55 to show the best sensitivity–
specificity profile in identifying women suffering from 
any sexual dysfunction. The translated and culturally 
adapted Iranian version of the FSFI has shown excellent 
psychometric properties.23
Sexual distress. Participants’ concerns and distress relating 
to their sexual functioning were assessed using the Female 
Sexual Distress Scale-Revised (FSDS-R). The FSDS-R is 
a self-reported unidimensional measure consisting of 13 
items. All items are scored on a five-point Likert-type 
scale ranging from 0 (never) to 4 (always), with higher 
scores indicating more sexual distress. A total score can be 
calculated by summing up the 13 item scores. The Iranian 
version of the FSDS-R has demonstrated acceptable valid-
ity and reliability.24
HRQoL. Participants’ HRQoL was assessed using the Short 
Form-12 (SF-12), a self-administered health instrument 
consisting of 12 items. Two summary scores – the physical 
component summary (PCS) and the mental component 
summary (MCS) – can be computed. Higher scores in both 
components indicate higher HRQoL. The Iranian version 
of the SF-12 has been shown to be a psychometrically 
sound tool for assessment of HRQoL.25
Depressive symptoms and anxiety. Information on depres-
sive symptoms and anxiety was collected using the Hospi-
tal Anxiety and Depression Scale (HADS), a 14-item 
instrument consisting of seven items related to anxiety and 
depressive symptoms, respectively. All items are scored on 
a four-point Likert-type scale ranging from 0 (not at all) to 
3 (very much indeed), with higher scores indicating more 
psychological distress. The Iranian version of the HADS 
has been found to be highly valid and reliable for detecting 
states of depressive symptoms and anxiety.26
Statistical analysis. Data are presented as means with 
standard deviations (SD) or as frequency and percentages. 
The comparability of the three groups in terms of sociode-
mographic and clinical variables was assessed using 
one-way analysis of variance (one-way ANOVA) for con-
tinuous measures and chi-square statistics for categorical 
variables. To analyze the longitudinal data, multilevel 
modeling (MLM; MLwiN version 2.27) was conducted to 
determine the effects of the psychosocial factors on sexual 
functioning over time. MLM is a powerful method that 
allows examination of changes over time by simultane-
ously accounting for within-individual and between-
individual effects. Several univariate multilevel analyses 
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were conducted first to identify potential confounder 
variables such as age, income, body mass index, comor-
bidities and years of education. Following these analyses, 
variables with a p-value < 0.15 were treated as confound-
ers and subsequently entered into the multiple-variable 
models. Next, restricted iterative generalized least squares 
was applied to fit all MLM models to three levels: time 
was set at the first level, participants at the second level, 
and hospitals at the third level. A logistic binary multi-
level regression was performed to measure the changes in 
prevalence of sexual problems across time and across 
the three study groups. To test whether the decrease in 
patients’ HRQoL (i.e. PCS and MCS) resulting from anxi-
ety was associated with sexual functioning and sexual dis-
tress, mediation analyses based on Krull and MacKinnon’s 
recommendations were performed.27 All p-values were 
adjusted for multiple comparisons using the Benjamini 
and Hochberg false discovery rate,28 and p⩽0.05 was 
considered statistically significant.
Results
The sociodemographic and clinical characteristics of the 
three groups are presented in Table 1. Women were 53 to 
68 years old with a median education of four years (inter-
quartile range: 4–7). Eighteen percent of women in the 
TSCM group, 20% in the AMI group and 17% of the 
healthy control were menopausal. Overall, cardiac risk 
factors (i.e. smoking, diabetes, hypertension and hyperlipi-
demia) were more common in the TSCM and AMI groups 
compared with the healthy controls (Table 1).
Table 2 shows the means and SDs for psychological 
distress, female sexual functioning and HRQoL for all 
three study groups at baseline and at six- and 18-month 
follow-up. The TSCM group reported higher scores at 
baseline for sexual distress, anxiety and depression 
compared with the AMI and the healthy control groups 
(p<0.05). At baseline, both the TSCM and the AMI group 
reported lower PCS and sexual functioning compared with 
the healthy controls but no significant differences in these 
variables could be detected between the TSCM and the 
AMI groups.
According to the MLM models, sexual functioning 
scores differed significantly between the three groups at 
baseline (Table 3). Overall, the TSCM group showed 
significantly worse sexual functioning across all six 
dimensions over time compared with the AMI group 
(coefficients = −0.57 to −0.15, p < 0.001 at six-month 
follow-up; coefficients = −0.52 to −0.11, p < 0.001 at 
18-month follow-up) and the healthy controls (coeffi-
cients = −2.19 to −0.29, p < 0.001 at six-month follow-
up; coefficients = −2.23 to −0.25, p < 0.001 at 18-month 
follow-up) (Table 3).
Table 4 displays the mediating effects of female sex-
ual functioning and sexual distress in the association 
between anxiety and HRQoL in the TSCM group. Here, 
anxiety was negatively associated with both the PCS 
(coefficient = −1.89, p < 0.001 at six months; coefficient 
= −1.54, p < 0.001 at 18 months) and the MCS score 
(coefficient = −1.92, p < 0.001 at six months; coefficient 
= −1.71, p < 0.001 at 18 months). In addition, significant 
mediating effects of female sexual functioning (coeffi-
cient = −0.65 and −1.45 for PCS, p < 0.001; coefficient = 
−2.63 and −2.09 for MCS, p < 0.01) and sexual distress 
(coefficient = −0.39 and −2.05 for PCS, p<0.05; coeffi-
cient = −2.61 and −1.73 for MCS, p < 0.01) could be 
found in the relationship between anxiety and both the 
PCS and MCS score.
General patterns of changes in prevalence of sexual 
problems are shown in Figure 1. Patients with TSCM 
reported higher prevalence of sexual problems across 
time compared with the healthy controls (odds ratio 
Table 1. Socio-demographic characteristics by condition.
Control (n=94) AMI (n=94) TSCM (n=94) p-value
 
Age, years, mean ± SD 63.10 ± 6.45 62.81 ± 8.33 63.56 ± 7.48 0.92
Years of education, years, mean ± SD 5.99 ± 1.31 5.69 ± 1.26 5.80 ± 1.36 0.58
BMI, mean ± SD 22.52 ± 4.54 23.51 ± 4.13 22.98 ± 3.74 0.27
Monthly family income, n (%) 0.46
 High, >US$1000 29 (30.85) 39 (41.49) 31(32.98)  
 Intermediate, US$500–1000 32 (34.05) 28 (29.79) 37 (39.36)  
 Low, < US$500 33 (35.10) 27 (28.72) 26 (27.66)  
Smoking, n (%) 21 (22.34) 31 (32.98) 26 (27.66) 0.06
Diabetes, n (%) 1 (1.06) 17 (18.08) 9 (9.57) 0.003
Hypertension, n (%) 11 (11.70) 53 (56.38) 51 (54.25) <0.001
Hyperlipidemia, n (%) 17 (18.05) 49 (52.13) 32 (34.04) <0.001
Menopause, n (%) 16 (17.02) 19 (20.21) 17 (18.05) 0.33
Female sexual dysfunction, n (%) 53 (56.38) 71 (75.53) 73 (77.66) <0.001
AMI: acute myocardial infarction; TSCM: Takotsubo (stress) cardiomyopathy; BMI: body mass index.
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(OR)= 3.10, p= 0.001) and the AMI group (OR= 2.28, 
p= 0.001).
Discussion
In this multi-center longitudinal study we found that the 
symptoms of anxiety and depression were more frequent, 
while HRQoL and sexual function were significantly lower 
in female patients with TSCM compared with healthy con-
trols. Women with TSCM further showed less favorable 
outcomes across all study variables except for HRQoL 
(physical functioning) compared with the AMI group. 
Sexual functioning showed a stronger decline over time in 
the TSCM group compared with the AMI group and turned 
out to be a mediator in the relationship between anxiety and 
HRQoL. Finally, while anxiety and depression increased 
over time, HRQoL and sexual function tended to decrease in 
both groups but especially in the TSCM group, potentially 
indicating a reversed association between these variables.
Findings from a number of studies have shown that 
female patients reporting AMI or TSCM also report higher 
levels of mental, physical and overall health impairment 
compared with the general population.5,29,30 A study by 
Christensen et al., for example, found that neuroticism, 
depression and anxiety were considerably higher in patients 
with TSCM compared with the healthy general popula-
tion.31 When comparing TSCM and AMI patients, the 
authors further observed higher levels of anxiety in the 
Table 2. Descriptive statistics for all outcome measures by condition and time.
Variable Condition Baseline Month 6 Month 18
 Mean ± SD Mean ± SD Mean ± SD
Anxiety Control 5.39 ± 1.63 5.41 ± 1.57 5.38 ± 1.51
AMI 8.75 ± 2.88 8.79 ± 2.13 8.77 ± 2.47
TSCM 9.68 ± 2.63 9.81 ± 2.31 9.83 ± 2.59
Depression Control 5.26 ± 1.49 5.22 ± 1.31 5.25 ± 1.40
AMI 7.22 ± 3.53 6.68 ± 2.78 6.64 ± 2.41
TSCM 7.37 ± 4.44 7.73 ± 4.06 7.71 ± 4.12
Desire Control 3.27 ± 1.20 3.26 ± 1.46 3.30 ± 1.27
AMI 2.30 ± 1.01 2.27 ± 1.12 2.28 ± 1.11
TSCM 2.25 ± 0.78 2.03 ± 0.71 1.95 ± 0.58
Arousal Control 3.08 ± 1.58 3.05 ± 1.37 3.10 ± 1.41
AMI 2.24 ± 0.91 2.19 ± 0.91 2.12 ± 0.88
TSCM 2.22 ± 0.59 1.80 ± 0.50 1.72 ± 0.51
Lubrication Control 3.66 ± 1.18 3.69 ± 1.10 3.65 ± 1.15
AMI 2.63 ± 0.88 2.51 ± 0.83 2.50 ± 0.80
TSCM 2.59 ± 0.64 2.34 ± 0.55 2.29 ± 0.51
Orgasm Control 4.21 ± 1.72 4.23 ± 1.77 4.22 ± 1.69
AMI 2.56 ± 0.91 2.50 ± 0.84 2.47 ± 0.85
TSCM 2.54 ± 0.78 2.20 ± 0.77 2.14 ± 0.70
Satisfaction Control 3.78 ± 1.76 3.80 ± 1.81 3.81 ± 1.80
AMI 2.81 ± 0.88 2.70 ± 0.81 2.68 ± 0.80
TSCM 2.80 ± 0.93 2.46 ± 0.71 2.41 ± 0.65
Pain Control 3.99 ± 1.14 3.98 ± 1.10 4.00 ± 1.20
AMI 3.91 ± 0.86 3.07 ± 0.80 3.00 ± 0.78
TSCM 3.92 ± 0.85 2.95 ± 0.73 2.89 ± 0.77
Total FSFI Control 22.35 ± 3.58 22.38 ± 3.49 22.54 ± 3.62
AMI 16.45 ± 3.01 15.26 ± 3.08 15.09 ± 2.98
TSCM 16.33 ± 3.30 13.81 ± 3.24 12.48 ± 3.19
FSDS-R Control 5.90 ± 2.71 5.94 ± 2.77 5.93 ± 2.69
AMI 13.97 ± 5.34 14.08 ± 5.38 14.13 ± 5.41
TSCM 16.78 ± 5.72 17.16 ± 5.82 17.23 ± 5.64
PCS Control 74.31 ± 10.82 73.92 ± 10.28 74.33 ± 10.61
AMI 44.81 ± 7.34 34.51 ± 6.25 31.22 ± 6.11
TSCM 44.16 ± 6.11 40.68 ± 6.01 38.12 ± 5.88
MCS Control 62.31 ± 9.58 61.42 ± 9. 61 61.34 ± 9.52
AMI 45.49 ± 7.46 43.71 ± 7.10 42.32 ± 7.17
TSCM 41.66 ± 7.38 35.14 ± 6.87 31.23 ± 6.67
AMI: acute myocardial infarction; TSCM: Takotsubo (stress) cardiomyopathy; FSFI: Female Sexual Function Index; FSDS-R: Female Sexual Distress 
Scale-Revised; PCS: physical component summary; MCS: mental component summary.
Saffari et al. 619
T
ab
le
 3
. 
T
hr
ee
-le
ve
l m
ul
tip
le
 li
ne
ar
 r
eg
re
ss
io
n 
m
od
el
s 
pr
ed
ic
tin
g 
de
si
re
, a
ro
us
al
, l
ub
ri
ca
tio
n,
 o
rg
as
m
, s
at
is
fa
ct
io
n,
 p
ai
n 
an
d 
to
ta
l s
co
re
 o
f t
he
 F
SF
I.
V
ar
ia
bl
e
M
on
th
D
es
ir
e
A
ro
us
al
Lu
br
ic
at
io
n
O
rg
as
m
Sa
tis
fa
ct
io
n
Pa
in
FS
FI
 
β
 (
SE
)
p-
va
lu
e
β
 (
SE
)
p-
va
lu
e
β
 (
SE
)
p-
va
lu
e
β
 (
SE
)
p-
va
lu
e
β
 (
SE
)
p-
va
lu
e
β
 (
SE
)
p-
va
lu
e
β
 (
SE
)
p-
va
lu
e
A
M
I
−
0.
28
 (
0.
06
)
<
0.
00
1
−
0.
12
 (
0.
04
)
0.
00
2
−
0.
20
 (
0.
06
)
<
0.
00
1
−
0.
22
 (
0.
07
)
0.
00
2
−
0.
16
 (
0.
09
)
0.
07
−
0.
02
 (
0.
10
)
0.
84
−
0.
74
 (
0.
45
)
0.
10
T
SC
M
−
0.
37
 (
0.
06
)
<
0.
00
1
−
0.
18
 (
0.
03
)
<
0.
00
1
−
0.
38
 (
0.
08
)
<
0.
00
1
−
0.
27
 (
0.
05
)
<
0.
00
1
−
0.
24
 (
0.
07
)
<
0.
00
1
−
0.
14
 (
0.
07
)
0.
04
5
−
0.
28
 (
0.
16
)
0.
08
M
on
th
6
−
0.
59
 (
0.
07
)
<
0.
00
1
−
0.
17
 (
0.
04
)
<
0.
00
1
−
0.
41
 (
0.
06
)
<
0.
00
1
−
0.
42
 (
0.
11
)
<
0.
00
1
−
0.
20
 (
0.
06
)
<
0.
00
1
−
0.
12
 (
0.
05
)
0.
01
6
−
1.
74
 (
0.
41
)
<
0.
00
1
A
M
I v
s. 
co
nt
ro
l
6
−
0.
27
 (
0.
10
)
0.
00
7
−
0.
12
 (
0.
05
)
0.
01
6
−
0.
26
 (
0.
05
)
<
0.
00
1
−
0.
19
 (
0.
03
)
<
0.
00
1
−
0.
22
 (
0.
08
)
0.
00
6
−
0.
21
 (
0.
10
)
0.
03
−
1.
62
 (
0.
61
)
0.
00
7
T
SC
M
 v
s. 
co
nt
ro
l
6
−
0.
56
 (
0.
11
)
<
0.
00
1
−
0.
29
 (
0.
06
)
<
0.
00
1
−
0.
32
 (
0.
06
)
<
0.
00
1
−
0.
29
 (
0.
04
)
<
0.
00
1
−
0.
30
 (
0.
03
)
<
0.
00
1
−
0.
59
 (
0.
14
)
<
0.
00
1
−
2.
19
 (
0.
66
)
<
0.
00
1
T
SC
M
 v
s. 
A
M
I
6
−
0.
24
 (
0.
10
)
0.
01
6
−
0.
16
 (
0.
07
)
0.
02
−
0.
41
 (
0.
11
)
<
0.
00
1
−
0.
15
 (
0.
07
)
0.
03
−
0.
24
 (
0.
09
)
0.
00
8
−
0.
38
 (
0.
16
)
0.
01
7
−
0.
57
 (
0.
18
)
0.
00
1
M
on
th
18
−
0.
57
 (
0.
07
)
<
0.
00
1
−
0.
14
 (
0.
05
)
0.
00
4
−
0.
52
 (
0.
09
)
<
0.
00
1
−
0.
12
 (
0.
05
)
0.
02
−
0.
04
 (
0.
09
)
0.
66
−
0.
16
 (
0.
09
)
0.
07
−
0.
46
 (
0.
06
)
<
0.
00
1
A
M
I v
s. 
co
nt
ro
l
18
−
0.
38
 (
0.
10
)
<
0.
00
1
−
0.
13
 (
0.
05
)
0.
00
9
−
0.
37
 (
0.
14
)
0.
00
8
−
0.
18
 (
0.
06
)
0.
00
3
−
0.
16
 (
0.
07
)
0.
02
−
0.
28
 (
0.
11
)
0.
01
−
1.
97
 (
0.
66
)
0.
00
2
T
SC
M
 v
s. 
co
nt
ro
l
18
−
0.
51
 (
0.
09
)
<
0.
00
1
−
0.
25
 (
0.
06
)
<
0.
00
1
−
0.
46
 (
0.
10
)
<
0.
00
1
−
0.
42
 (
0.
11
)
<
0.
00
1
−
0.
34
 (
0.
04
)
<
0.
00
1
−
0.
54
 (
0.
12
)
<
0.
00
1
−
2.
23
 (
0.
64
)
<
0.
00
1
T
SC
M
 v
s. 
A
M
I
18
−
0.
61
 (
0.
11
)
<
0.
00
1
−
0.
19
 (
0.
07
)
0.
00
7
−
0.
26
 (
0.
08
)
0.
00
1
−
0.
29
 (
0.
07
)
<
0.
00
1
−
0.
11
 (
0.
05
)
0.
03
−
0.
32
 (
0.
13
)
0.
01
−
0.
52
 (
0.
24
)
0.
03
A
nx
ie
ty
−
0.
39
 (
0.
02
)
<
0.
00
1
−
0.
12
 (
0.
03
)
<
0.
00
1
−
0.
23
 (
0.
09
)
0.
01
−
0.
18
 (
0.
09
)
0.
04
5
−
0.
10
 (
0.
04
)
0.
01
−
0.
21
 (
0.
06
)
<
0.
00
1
−
0.
74
 (
0.
13
)
<
0.
00
1
D
ep
re
ss
io
n
−
0.
21
 (
0.
04
)
<
0.
00
1
−
0.
02
 (
0.
01
)
0.
04
5
−
0.
11
 (
0.
04
)
0.
00
6
−
0.
29
 (
0.
08
)
<
0.
00
1
−
0.
14
 (
0.
08
)
0.
08
−
0.
09
 (
0.
05
)
0.
07
−
0.
18
 (
0.
07
)
0.
10
Se
xu
al
 d
is
tr
es
s
−
0.
24
 (
0.
07
)
<
0.
00
1
−
0.
47
 (
0.
12
)
<
0.
00
1
−
0.
32
 (
0.
14
)
0.
02
2
−
0.
25
 (
0.
04
)
<
0.
00
1
−
0.
23
 (
0.
04
)
<
0.
00
1
−
0.
14
 (
0.
05
)
0.
00
5
−
0.
26
 (
0.
08
)
0.
00
1
PC
S
0.
14
 (
0.
02
)
<
0.
00
1
0.
06
 (
0.
02
)
0.
00
3
0.
28
 (
0.
18
)
0.
12
0.
09
 (
0.
05
)
0.
07
0.
10
 (
0.
05
)
0.
04
5
0.
03
 (
0.
02
)
0.
13
0.
17
 (
0.
05
)
<
0.
00
1
M
C
S
0.
43
 (
0.
09
)
<
0.
00
1
0.
30
 (
0.
08
)
<
0.
00
1
  (
0.
42
 (
0.
11
)
<
0.
00
1
0.
31
 (
0.
06
)
<
0.
00
1
0.
18
 (
0.
06
)
0.
00
3
−
0.
18
 (
0.
03
)
<
0.
00
1
0.
16
 (
0.
06
)
0.
00
7
D
ia
be
te
s
−
0.
13
 (
0.
06
)
0.
03
1
−
0.
03
 (
0.
04
)
0.
45
−
0.
11
 (
0.
09
)
0.
22
−
0.
16
 (
0.
11
)
0.
15
−
0.
08
 (
0.
05
)
0.
11
0.
04
 (
0.
06
)
0.
50
−
0.
86
 (
0.
76
)
0.
26
Sm
ok
in
g
−
0.
02
 (
0.
04
)
0.
61
−
0.
08
 (
0.
05
)
0.
11
−
0.
04
 (
0.
03
)
0.
18
−
0.
19
 (
0.
09
)
0.
03
0.
04
 (
0.
05
)
0.
42
−
0.
 1
4 
(0
.1
1)
0.
20
−
0.
10
 (
0.
26
)
0.
70
H
yp
er
te
ns
io
n
−
0.
06
 (
0.
04
)
0.
13
−
0.
58
 (
0.
36
)
0.
11
−
0.
06
 (
0.
02
)
0.
00
3
−
0.
05
 (
0.
07
)
0.
47
−
0.
07
 (
0.
06
)
0.
24
−
0.
10
 (
0.
06
)
0.
09
−
0.
75
 (
0.
30
)
0.
12
H
yp
er
lip
id
em
ia
0.
04
 (
0.
05
)
0.
42
−
0.
47
 (
0.
24
)
0.
04
9
0.
12
 (
0.
08
)
0.
13
−
0.
04
 (
0.
02
)
0.
04
5
−
0.
09
 (
0.
08
)
0.
25
0.
08
 (
0.
07
)
0.
25
−
0.
37
 (
0.
27
)
0.
17
In
te
rc
ep
t
0.
79
 (
0.
02
)
<
0.
00
1
0.
98
 (
0.
09
)
<
0.
00
1
0.
73
 (
0.
04
)
<
0.
00
1
0.
32
 (
0.
02
)
<
0.
00
1
0.
48
 (
0.
01
<
0.
00
1
0.
60
 (
0.
04
)
<
0.
00
1
34
.6
0 
(0
.9
2)
<
0.
00
1
A
M
I: 
ac
ut
e 
m
yo
ca
rd
ia
l i
nf
ar
ct
io
n;
 T
SC
M
: T
ak
ot
su
bo
 (
st
re
ss
) 
ca
rd
io
m
yo
pa
th
y;
 P
C
S:
 p
hy
si
ca
l c
om
po
ne
nt
 s
um
m
ar
y;
 M
C
S:
 m
en
ta
l c
om
po
ne
nt
 s
um
m
ar
y;
 F
SF
I: 
Fe
m
al
e 
Se
xu
al
 F
un
ct
io
n 
In
de
x.
620 European Journal of Cardiovascular Nursing 16(7)
Table 4. Female sexual dysfunction and quality of life, mediators and mediation effect in patients with Takotsubo (stress) 
cardiomyopathy.
Outcome Time, 
month
Mediator Anxiety effect 
on outcome
C (SE)
Anxiety effect 
on mediator
A (SE)
Mediator effect 
on outcome
B (SE)
Mediated effect 
A*B (SE)
PCS 6 −1.89 (0.12)***  
 FSFI −1.23 (0.07)*** 0.53 (0.12)*** −0.65 (0.15)***
 FSDS-R 1.16 (0.06)*** −0.34 (0.16)* −0.39 (0.18)*
 18 −1.54 (0.18)***  
 FSFI −1.42 (0.11)*** 1.02 (0.13)*** −1.45 (0.22)***
 FSDS-R 1.25 (0.09)*** −1.64 (0.19)*** −2.05 (0.28)***
MCS 6 −1.92 (0.26)***  
 FSFI −1.83 (0.10)*** 1.44 (0.24)*** −2.63 (0.46)***
 FSDS-R 1.28 (0.26)*** −2.04 (0.43)*** −2.61 (0.76)***
 18 −1.71 (0.35)***  
 FSFI −1.63 (0.49)*** 1.28 (0.19)*** −2.09 (0.70)**
 FSDS-R 1.21 (0.32)*** −1.43 (0.28)*** −1.73 (0.57)**
*p<0.05.
**p<0.01.
***p<0.001.
PCS: physical component summary; MCS: mental component summary; FSFI: Female Sexual Function Index; FSDS-R: Female Sexual Distress Scale-Revised.
TSCM group compared with the AMI group. In another, 
similar, study, Goh et al. found a higher level of anxiety, but 
not depression, in the TSCM group compared with women 
with AMI.21 Somewhat in accordance with these previous 
findings we were also able to observe differences in anxiety, 
depression and overall psychological health between female 
patients with TSCM, those with AMI and healthy controls.
In terms of sexual health, women with TSCM reported 
more sexual problems and also showed a stronger decline 
over time in functioning compared with the AMI group 
and the healthy controls. We further detected a mediating 
effect of sexual functioning in the association between 
anxiety and HRQoL in the TSCM group. In other words, 
with increasing anxiety and decreasing HRQoL, sexual 
functioning also decreased over time. The importance 
of anxiety in sexual functioning has been investigated in 
other studies and study populations, such as patients with 
AMI. A study by Oskay et al.,12 for example, found that 
nearly 75% of women with AMI suffered from some sort of 
sexual dysfunction and scored lower in all domains of the 
FSFI compared with healthy controls. In line with previous 
findings in patients with AMI, we also found higher levels 
of sexual problems in women with TSCM and even 
observed a steeper decline in sexual functioning over time 
compared with AMI or healthy controls. This may be 
explained by the increase of anxiety over time. Indeed, evi-
dence suggests that anxiety can negatively impact on sex-
ual functioning, and without appropriate intervention lead 
Figure 1. General patterns of change in prevalence of sexual dysfunction among study groups including patients with Takotsubo 
(stress) cardiomyopathy (TSCM), patients with acute myocardial infarction (AMI) and control group.
Saffari et al. 621
to worsening and further deterioration of sexual function-
ing in a progressive pattern.
Limitations
Certain limitations need to be considered. First, although a 
longitudinal study design with low attrition was used, data 
were collected by self-report, which may have led to recall 
or information biases. Second, despite our attempts to 
match the three study groups for sociodemographic charac-
teristics, some differences, for example in terms of clinical 
conditions such as diabetes and hypertension, may have led 
to confounding and limited the comparability of the sam-
ples. Finally, other factors such as social support and differ-
ences in coping strategies that have previously been shown 
to influence sexual functioning were not explored in the 
current study due to the unavailability of the data.
Conclusion
In conclusion, our study findings indicate that depressive 
symptoms, anxiety, HRQoL and sexual functioning are 
impaired in women with TSCM. Women with AMI also 
showed higher levels of impairment compared with healthy 
controls but were less affected compared with women with 
TSCM. Sexual functioning further turned out to be a medi-
ator that could negatively influence HRQoL over time. 
Future studies are needed to increase our understanding of 
such mediation mechanisms. Based on our findings we 
conclude that there is an urgent need to design health inter-
ventions for preventing exacerbation of mental conditions 
and sexual problems in female patients with TSCM.
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